LABORATORIO FARMAC.ERFO (RK7) — Financial Flexibility Index
LABORATORIO FARMAC.ERFO (RK7) has a Financial Flexibility Index of 1.21x as of December 2023. Free cash flow of €2.74 Million (operating CF €1.30 Million minus capex €1.45 Million) represents 1% of total liabilities (€2.26 Million). Also explore how fast is LABORATORIO FARMAC.ERFO growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LABORATORIO FARMAC.ERFO Financial Flexibility Index (2021–2023)
Historical Financial Flexibility Index trend for LABORATORIO FARMAC.ERFO across 3 annual periods. See LABORATORIO FARMAC.ERFO balance sheet quality to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year free cash flow to debt coverage for LABORATORIO FARMAC.ERFO. For the full company profile including market capitalisation, see LABORATORIO FARMAC.ERFO (RK7) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.21x | €2.74 Million | €1.30 Million | €2.26 Million | ▲ +557.6% |
| 2022 | 0.18x | €1.94 Million | €761.80K | €10.53 Million | ▼ -83.9% |
| 2021 | 1.14x | €2.52 Million | €2.27 Million | €2.21 Million | — |